alnylam
The Director of Strategic Pricing & Contracting Analytics leads the analytic, financial, and operational capabilities supporting pricing and contracting decision-making across the organization. This role partners with cross-functional teams to deliver actionable insights, develop scalable capabilities, and drive process innovation to improve decision quality and execution. The position serves as the primary business lead for deal modeling, contracting analytics, data governance, and reporting initiatives.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2002
Alnylam is a biopharmaceutical company that has pioneered RNA interference (RNAi) therapeutics, an innovative class of medicines that treats diseases by silencing the genes that cause or contribute to them. The company develops RNAi-based medicines targeting both rare and prevalent diseases across multiple therapeutic areas, with approved products and a robust investigational pipeline. Driven by science and inspired by patients, Alnylam is committed to delivering transformational medicines that address diseases at their genetic source.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for alnylam.
Associate Manager, Contracting Analytics
Regeneron Pharmaceuticals
Director, Pricing Implementation & Performance Analytics
Cytokinetics
Executive Director, Pricing Strategy, Analytics & Contracting
Madrigal Pharmaceuticals
Pricing and Contracting Manager
Cytokinetics
Associate Director, Pricing Strategy & Access Analytics
Amylyx Pharmaceuticals
Director, Strategic Pricing & Analytics
INSPYR Solutions